← Open Payments lookup

DAVID CALIFF: Open Payments

NPI 1407537145 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,782 in 98 payments from 14 companies in 2025. Trend: 2023 $801 · 2024 $1,574 · 2025 $1,782

Food & beverage: $1,781Education: $1
CompanyPaymentsAmount
ABBVIE INC.31$479
Supernus Pharmaceuticals, Inc.20$311
Alkermes, Inc.10$205
Vanda Pharmaceuticals Inc.6$146
Teva Pharmaceuticals USA, Inc.4$82
Janssen Pharmaceuticals, Inc4$81
Otsuka America Pharmaceutical, Inc.4$78
Neurocrine BioSciences, Inc.3$68
E.R. Squibb & Sons, L.L.C.3$66
Collegium Pharmaceutical, Inc.3$63

Products named: VRAYLAR, Qelbree, ARISTADA, FANAPT, REXULTI, INGREZZA, COBENFY, Jornay PM.

Industry payments across WA — which companies pay providers there.